Biological basis of late life depression

Current Psychiatry Reports

Volumn 14, Issue 4, 2012, Pages 273-279

  Disabato, Brianne M ^a   Sheline, Yvette I ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive deficits; Elderly; Inflammatory markers; Ischemic lesion burden; Late life depression; LLD; Neuropsychological factors; Structural neuroimaging; Treatment outcome; White matter hyperintensities

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; NORTRIPTYLINE; SERTRALINE;

ARTICLE; BRAIN SIZE; COGNITIVE DEFECT; EPISODIC MEMORY; HUMAN; LATE LIFE DEPRESSION; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; TREATMENT OUTCOME; WHITE MATTER;

AGE OF ONSET; AGED; AGED, 80 AND OVER; BRAIN; COGNITION DISORDERS; CYTOKINES; DEPRESSIVE DISORDER; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; NEUROIMAGING;

EID: 84865658769     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-012-0279-6     Document Type: Article

References (98)

1. Lee SH, Payne ME, Steffens DC, McQuoid DR, Lai TJ, Provenzale JM, et al. Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression. Biol Psychiatry. 2003;54(5):529-33. (Pubitemid 37289439)
2. Ballmaier M, Toga AW, Blanton RE, Sowell ER, Lavretsky H, Peterson J, et al. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am J Psychiatry. 2004;161(1):99-108. (Pubitemid 38419314)
3. Dotson VM, Davatzikos C, Kraut MA, Resnick SM. Depressive symptoms and brain volumes in older adults: a longitudinal magnetic resonance imaging study. J Psychiatry Neurosci. 2009;34 (5):367-75.
4. Lavretsky H, Ballmaier M, Pham D, Toga A, Kumar A. Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study. Am J Geriatr Psychiatry. 2007;15(5):386-94. doi:10.1097/JGP. 0b013e3180325a16.
5. Elderkin-Thompson V, Hellemann G, Pham D, Kumar A. Prefrontal brain morphology and executive function in healthy and depressed elderly. Int J Geriatr Psychiatry. 2009;24(5):459-68. doi:10.1002/gps.2137.
6. Steffens DC, Byrum CE, McQuoid DR, Greenberg DL, Payne ME, Blitchington TF, et al. Hippocampal volume in geriatric depression. Biol Psychiatry. 2000;48(4):301-9. (Pubitemid 30645800)
7. O'Brien JT, Lloyd A, McKeith I, Gholkar A, Ferrier N. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry. 2004;161(11):2081-90. doi:10.1176/appi.ajp.161.11. 2081. (Pubitemid 39441410)
8. Andreescu C, Butters MA, Begley A, Rajji T, Wu M, Meltzer CC, et al. Gray matter changes in late life depression-a structural MRI analysis. Neuropsychopharmacology. 2008;33(11):2566-72. doi:10.1038/sj.npp.1301655.
9. Butters MA, Aizenstein HJ, Hayashi KM, Meltzer CC, Seaman J, Reynolds 3rd CF, et al. Three-dimensional surface mapping of the caudate nucleus in late-life depression. Am J Geriatr Psychiatry. 2009;17(1):4-12. doi:10.1097/JGP.0b013e31816ff72b.
10. Burke J, McQuoid DR, Payne ME, Steffens DC, Krishnan RR, Taylor WD. Amygdala volume in late-life depression: relationship with age of onset. Am J Geriatr Psychiatry. 2011;19(9):771-6. doi:10.1097/JGP.0b013e318211069a.
11. Goveas JS, Espeland MA, Hogan P, Dotson V, Tarima S, Coker LH, et al. Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the Women's Health Initiative MRI Study. J Affect Disord. 2011;132(1-2):275-84. doi:10.1016/j.jad.2011.01.020.
12. Tamburo RJ, Siegle GJ, Stetten GD, Cois CA, ButtersMA, Reynolds 3rd CF, et al. Amygdalae morphometry in late-life depression. Int J Geriatr Psychiatry. 2009;24(8):837-46. doi:10.1002/gps.2167.
13. Zhao Z, Taylor WD, Styner M, Steffens DC, Krishnan KR, MacFall Jr. Hippocampus shape analysis and late-life depression. PLoS One. 2008;3(3):e1837. doi:10.1371/journal.pone.0001837. (Pubitemid 351936281)
14. Bell-McGinty S, Butters MA, Meltzer CC, Greer PJ, Reynolds 3rd CF, Becker JT. Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry. 2002;159(8):1424-7. (Pubitemid 34832728)
15. Gunning FM, Cheng J, Murphy CF, Kanellopoulos D, Acuna J, Hoptman MJ, et al. Anterior cingulate cortical volumes and treatment remission of geriatric depression. Int J Geriatr Psychiatry. 2009;24(8):829-36. doi:10.1002/gps.2290. This recent 12-week controlled treatment trial of escitalopram examined the relationship between brain structure and treatment outcome. The results demonstrate that non-remitting LLD subjects have smaller anterior cingulate volumes.
16. Hsieh MH, McQuoid DR, Levy RM, Payne ME, MacFall JR, Steffens DC. Hippocampal volume and antidepressant response in geriatric depression. Int J Geriatr Psychiatry. 2002;17(6):519-25. doi:10.1002/gps.611. (Pubitemid 34678703)
17. Janssen J, Hulshoff Pol HE, Schnack HG, Kok RM, Lampe IK, de Leeuw FE, et al. Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression. Int J Geriatr Psychiatry. 2007;22(5):468-74. doi:10.1002/gps.1790. (Pubitemid 46831691)
18. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry. 1997;154(4):497-501. (Pubitemid 27147602)
19. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 'Vascular depression' hypothesis. Arch Gen Psychiatry. 1997;54(10):915-22.
20. Dufouil C, de Kersaint-Gilly A, Besancon V, Levy C, Auffray E, Brunnereau L, et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology. 2001;56(7):921-6. (Pubitemid 32290809)
21. Novak V, Last D, Alsop DC, Abduljalil AM, Hu K, Lepicovsky L, et al. Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care. 2006;29(7):1529-34. doi:10.2337/dc06-0261. (Pubitemid 44127576)
22. Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke. 2004;35(8):1857-61. doi:10.1161/01.STR.0000135226. 53499.85. (Pubitemid 38971865)
23. DeCarli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, et al. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging. 2005;26(4):491-510. doi:10.1016/j. neurobiolaging.2004.05.004. (Pubitemid 40093933)
24. Mirsen TR, Lee DH,Wong CJ, Diaz JF, Fox AJ, Hachinski VC, et al. Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. Arch Neurol. 1991;48(10):1015-21.
25. Awad IA, Johnson PC, Spetzler RF, Hodak JA. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke. 1986;17(6):1090-7. (Pubitemid 17008935)
26. Raz N, Rodrigue KM, Kennedy KM, Acker JD. Vascular health and longitudinal changes in brain and cognition in middle-aged and older adults. Neuropsychology. 2007;21(2):149-57. doi:10.1037/0894-4105.21.2.149. (Pubitemid 46631097)
27. Sachdev P,WenW, Chen X, Brodaty H. Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology. 2007;68(3):214-22. doi:10.1212/01.wnl.0000251302.55202.73. (Pubitemid 46105740)
28. Brown FW, Lewine RJ, Hudgins PA, Risch SC. White matter hyperintensity signals in psychiatric and nonpsychiatric subjects. Am J Psychiatry. 1992;149(5):620-5.
29. Coffey CE, Wilkinson WE, Weiner RD, Parashos IA, Djang WT, Webb MC, et al. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry. 1993;50(1):7-16. (Pubitemid 23026982)
30. Greenwald BS, Kramer-Ginsberg E, Krishnan RR, Ashtari M, Aupperle PM, Patel M. MRI signal hyperintensities in geriatric depression. Am J Psychiatry. 1996;153(9):1212-5. (Pubitemid 26299844)
31. Steffens DC, Bosworth HB, Provenzale JM,MacFall Jr. Subcortical white matter lesions and functional impairment in geriatric depression. Depress Anxiety. 2002;15(1):23-8. doi:10.1002/da.1081. (Pubitemid 34160262)
32. Taylor WD, MacFall JR, Payne ME, McQuoid DR, Steffens DC, Provenzale JM, et al. Greater MRI lesion volumes in elderly depressed subjects than in control subjects. Psychiatry Res. 2005;139(1):1-7. doi:10.1016/j.pscychresns.2004.08. 004. (Pubitemid 40800432)
33. O'Brien JT, Firbank MJ, Krishnan MS, van Straaten EC, van der Flier WM, Petrovic K, et al. White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study. Am J Geriatr Psychiatry. 2006;14(10):834-41. doi:10.1097/01.JGP. 0000214558.63358.94. (Pubitemid 44556477)
34. Sheline YI, Price JL, Vaishnavi SN, Mintun MA, Barch DM, Epstein AA, et al. Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry. 2008;165(4):524-32. doi:10.1176/appi. ajp.2007.07010175. (Pubitemid 351694296)
35. Sheline YI, Pieper CF, Barch DM, Welsh-Boehmer K, McKinstry RC, MacFall JR, et al. Support for the vascular depression hypothesis in late-life depression results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiat. 2010;67(3):277-85. This large, prospective 12 week treatment trial with sertraline demonstrated the relationship between neuropsychological factors, white matter hyperintensities, and treatment outcomes, providing additional support to the vascular depression hypothesis.
36. Iidaka T, Nakajima T, Kawamoto K, Fukuda H, Suzuki Y, Maehara T, et al. Signal hyperintensities on brain magnetic resonance imaging in elderly depressed patients. Eur Neurol. 1996;36(5):293-9. (Pubitemid 26261661)
37. Churchill CM, Priolo CV, Nemeroff CB, Ranga K, Krishnan R, Breitner JCS. Occult subcortical magnetic-resonance findings in elderly depressives. Int J Geriatr Psych. 1991;6(4):213-6.
38. Miller DS, Kumar A, Yousem DM, Gottlieb GL. Mri high-intensity signals in late-life depression and Alzheimers-disease. Am J Geriat Psychiat. 1994;2(4):332-7.
39. Ebmeier KP, Prentice N, Ryman A, Halloran E, Rimmington JE, Best JK, et al. Temporal lobe abnormalities in dementia and depression: a study using high resolution single photon emission tomography and magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 1997;63(5):597-604. (Pubitemid 27489223)
40. Lloyd AJ, Ferrier IN, Barber R, Gholkar A, Young AH, O'Brien JT. Hippocampal volume change in depression: late-and early-onset illness compared. Br J Psychiatry. 2004;184:488-95. (Pubitemid 38725708)
41. Janssen J, Hulshoff Pol HE, de Leeuw FE, Schnack HG, Lampe IK, Kok RM, et al. Hippocampal volume and subcortical white matter lesions in late life depression: comparison of early and late onset depression. J Neurol Neurosurg Psychiatry. 2007;78(6):638-40. doi:10.1136/jnnp.2006.098087. (Pubitemid 46853904)
42. Delaloye C, Moy G, de Bilbao F, Baudois S, Weber K, Hofer F, et al. Neuroanatomical and neuropsychological features of elderly euthymic depressed patients with early-and late-onset. J Neurol Sci. 2010;299(1-2):19-23. doi:10.1016/j.jns.2010.08.046.
43. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin MP, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry. 1995;37(3):151-60.
44. O'Brien J, Ames D, Chiu E, Schweitzer I, Desmond P, Tress B. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ. 1998;317 (7164):982-4. (Pubitemid 28457258)
45. Simpson S, Baldwin RC, JacksonA, Burns AS. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med. 1998;28(5):1015-26. (Pubitemid 28458458)
46. Alexopoulos GS, Kiosses DN, Choi SJ, Murphy CF, Lim KO. Frontal white matter microstructure and treatment response of latelife depression: a preliminary study. Am J Psychiatry. 2002;159 (11):1929-32. (Pubitemid 35283262)
47. Alexopoulos GS, Murphy CF, Gunning-Dixon FM, Latoussakis V, Kanellopoulos D, Klimstra S, et al. Microstructural white matter abnormalities and remission of geriatric depression. AmJ Psychiatry. 2008;165(2):238-44. doi:10.1176/appi.ajp.2007.07050744. (Pubitemid 351704524)
48. Levy RM, Steffens DC, McQuoid DR, Provenzale JM, MacFall JR, Krishnan KR. MRI lesion severity and mortality in geriatric depression. Am J Geriatr Psychiatry. 2003;11(6):678-82. (Pubitemid 37392333)
49. Taylor WD, Steffens DC, MacFall JR, McQuoid DR, Payne ME, Provenzale JM, et al. White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry. 2003;60 (11):1090-6. doi:10.1001/archpsyc.60.11. 1090. (Pubitemid 37429648)
50. Baldwin R, Jeffries S, Jackson A, Sutcliffe C, Thacker N, Scott M, et al. Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors. Psychol Med. 2004;34(1):125-36. (Pubitemid 38139447)
51. Navarro V, Gasto C, Lomena F, Torres X, Mateos JJ, Portella MJ, et al. Prognostic value of frontal functional neuroimaging in late-onset severe major depression. Br J Psychiatry. 2004;184:306-11. (Pubitemid 38491165)
52. Patankar TF, Baldwin R, Mitra D, Jeffries S, Sutcliffe C, Burns A, et al. Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression. J Affect Disord. 2007;97(1-3):265-70. doi:10.1016/j.jad.2006.06.024.
53. Krishnan KR,Hays JC, George LK, Blazer DG. Six-month outcomes for MRI-related vascular depression. Depress Anxiety. 1998;8 (4):142-6. doi:10.1002/(SICI)1520-6394(1998)8:4<;142::AIDDA2>; 3.0.CO;2-N. (Pubitemid 29016523)
54. Salloway S, Boyle PA, Correia S, Malloy PF, Cahn-Weiner DA, Schneider L, et al. The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients. Am J Geriatr Psychiatry. 2002;10(1):107-11. (Pubitemid 34052909)
55. Sneed JR, Roose SP, Keilp JG, Krishnan KR, Alexopoulos GS, Sackeim HA. Response inhibition predicts poor antidepressant treatment response in very old depressed patients. Am J Geriatr Psychiatry. 2007;15(7):553-63. doi:10.1097/JGP.0b013e3180302513.
56. Teodorczuk A, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, et al. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med. 2010;40 (4):603-10. doi:10.1017/S0033291709990857.
57. Gunning-Dixon FM, Walton M, Cheng J, Acuna J, Klimstra S, Zimmerman ME, et al. MRI signal hyperintensities and treatment remission of geriatric depression. J Affect Disord. 2010;126 (3):395-401. doi:10.1016/j.jad.2010.04. 004.
58. Sneed JR, Culang-Reinlieb ME, Brickman AM, Gunning-Dixon FM, Johnert L, Garcon E, et al. MRI signal hyperintensities and failure to remit following antidepressant treatment. J Affect Disord. 2011;135(1-3):315-20. doi:10.1016/j.jad.2011.06.052. This is a small study, but examines the importance of whitematter hyperintensity location on treatment outcome. While lesion burden predictsoutcome, location may be less important.
59. Kramer-Ginsberg E, Greenwald BS, Krishnan KR, Christiansen B, Hu J, Ashtari M, et al. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. Am J Psychiatry. 1999;156(3):438-44. (Pubitemid 29124167)
60. Hart RP, Kwentus JA. Psychomotor slowing and subcortical-type dysfunction in depression. J Neurol Neurosurg Psychiatry. 1987;50 (10):1263-6. (Pubitemid 17150696)
61. Boone KB, Lesser IM, Miller BL, Wohl M, Berman N, Lee A, et al. Cognitive-functioning in older depressed outpatients -relationship of presence and severity of depression to neuropsychological test-scores. Neuropsychology. 1995;9(3):390-8.
62. Kohler S, Thomas AJ, Barnett NA, O'Brien JT. The pattern and course of cognitive impairment in late-life depression. Psychol Med. 2010;40(4):591-602. doi:10.1017/S0033291709990833.
63. •Sexton CE, McDermott L, Kalu UG, Herrmann LL, Bradley KM, Allan CL, et al. Exploring the pattern and neural correlates of neuropsychological impairment in late-life depression. Psychol Med. 2011:1-8. doi:10.1017/ S0033291711002352. This study examined neuropsychological factors and MRI correlates in LLD. Results indicate executive functioning and processing speed were signficant deficits in LLD subjects and affect other areas of cognition. MRI correlates support the involvement of the frontolimbic pathway in LLD.
64. Thomas AJ, O'Brien JT. Depression and cognition in older adults. Curr Opin Psychiatry. 2008;21(1):8-13. doi:10.1097/YCO.0b013e3282f2139b. (Pubitemid 351339801)
65. Butters MA, Becker JT, Nebes RD, Zmuda MD, Mulsant BH, Pollock BG, et al. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry. 2000;157 (12):1949-54.
66. Nebes RD, Butters MA, Houck PR, Zmuda MD, Aizenstein H, Pollock BG, et al. Dual-task performance in depressed geriatric patients. Psychiatry Res. 2001;102(2):139-51. (Pubitemid 32537662)
67. Nebes RD, Pollock BG, Houck PR, Butters MA, Mulsant BH, Zmuda MD, et al. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, doubleblind clinical trial with nortriptyline and paroxetine. J Psychiatr Res. 2003;37(2):99-108. (Pubitemid 36808472)
68. Murphy CF, Alexopoulos GS. Longitudinal association of initiation/perseveration and severity of geriatric depression. Am J Geriatr Psychiatry. 2004;12(1):50-6. (Pubitemid 38082394)
69. Bhalla RK, Butters MA, Mulsant BH, Begley AE, Zmuda MD, Schoderbek B, et al. Persistence of neuropsychologic deficits in the remitted state of late-life depression. Am J Geriatr Psychiatry. 2006;14(5):419-27. doi:10.1097/01.JGP. 0000203130.45421.69.
70. Sheline YI, Barch DM, Garcia K, Gersing K, Pieper C, Welsh-Bohmer K, et al. Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol Psychiatry. 2006;60(1):58-65. doi:10.1016/j.biopsych.2005.09.019.
71. Butters MA, Whyte EM, Nebes RD, Begley AE, Dew MA, Mulsant BH, et al. The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry. 2004;61(6):587-95. doi:10.1001/archpsyc.61.6. 587. (Pubitemid 38747313)
72. Delaloye C, Baudois S, de Bilbao F, Dubois Remund C, Hofer F, Lamon M, et al. Cognitive impairment in late-onset depression. Limited to a decrement in information processing resources? Eur Neurol. 2008;60(3):149-54. doi:10.1159/000144086.
73. Sanders JB, Bremmer MA, Comijs HC, Deeg DJ, Lampe IK, Beekman AT. Cognitive functioning and the natural course of depressive symptoms in late life. Am J Geriatr Psychiatry. 2011;19 (7):664-72. doi:10.1097/JGP. 0b013e3181f7d8e9.
74. Gallassi R, Di Sarro R, Morreale A, Amore M. Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy. J Affect Disord. 2006;91(2-3):243-50. doi:10.1016/j.jad.2006.01.018.
75. Mandelli L, Serretti A, Colombo C, Florita M, Santoro A, Rossini D, et al. Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: an exploratory analysis. Psychiatry Clin Neurosci. 2006;60(5):598-604. doi:10.1111/j.1440-1819.2006. 01564.x. (Pubitemid 44337482)
76. Shimony JS, Sheline YI, D'Angelo G, Epstein AA, Benzinger TL, Mintun MA, et al. Diffuse microstructural abnormalities of normal-appearing whitematter in late life depression: a diffusion tensor imaging study. Biol Psychiatry. 2009;66(3):245-52. doi:10.1016/j.biopsych.2009.02.032.
77. Kalayam B, Alexopoulos GS. Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry. 1999;56 (8):713-8. (Pubitemid 29357732)
78. Alexopoulos GS, Kiosses DN, Heo M, Murphy CF, Shanmugham B, Gunning-Dixon F. Executive dysfunction and the course of geriatric depression. Biol Psychiatry. 2005;58(3):204-10. doi:10.1016/j.biopsych.2005.04.024. (Pubitemid 41112268)
79. AlexopoulosGS, Murphy CF,Gunning-DixonFM,KalayamB, Katz R, Kanellopoulos D, et al. Event-related potentials in an emotional go/no-go task and remission of geriatric depression. Neuroreport. 2007;18(3):217-21. doi:10.1097/WNR. 0b013e328013ceda.
80. Story TJ, Potter GG, Attix DK, Welsh-Bohmer KA, Steffens DC. Neurocognitive correlates of response to treatment in late-life depression. AmJ Geriatr Psychiatry. 2008;16(9):752-9. doi:10.1097/JGP.0b013e31817e739a.
81. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004;39(5):687-99. doi:10.1016/j.exger.2004.01.009. (Pubitemid 38586809)
82. Moshage H. Cytokines and the hepatic acute phase response. J Pathol. 1997;181(3):257-66. doi:10.1002/(SICI)1096-9896 (199703)181:3<;257::AID- PATH756>;3.0.CO;2-U. (Pubitemid 27156836)
83. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000;157(5):683-94. (Pubitemid 30249643)
84. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology. 2001;26(8):761-88. (Pubitemid 32918282)
85. Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, et al. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord. 2008;106 (3):249-55. doi:10.1016/j.jad.2007.07.002.
86. Dentino AN, Pieper CF, Rao MK, Currie MS, Harris T, Blazer DG, et al. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc. 1999;47(1):6-11. (Pubitemid 29044260)
87. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun. 2001;15(3):199-226. doi:10.1006/brbi.2000.0597. (Pubitemid 33070955)
88. Kop WJ, Gottdiener JS, Tangen CM, Fried LP, McBurnie MA, Walston J, et al. Inflammation and coagulation factors in persons >; 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol. 2002;89(4):419-24. (Pubitemid 34142517)
89. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, et al. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry. 2003;54(5):566-72. (Pubitemid 37289443)
90. Tiemeier H, Hofman A, van Tuijl HR, Kiliaan AJ, Meijer J, Breteler MM. Inflammatory proteins and depression in the elderly. Epidemiology. 2003;14(1):103-7. doi:10.1097/01.EDE.0000037978. 71588.2A. (Pubitemid 40416821)
91. Panagiotakos DB, Pitsavos C, Chrysohoou C, Tsetsekou E, Papageorgiou C, Christodoulou G, et al. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J. 2004;25 (6):492-9. doi:10.1016/j.ehj.2004.01.018. (Pubitemid 38524274)
92. Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2004;164(9):1010-4. doi:10.1001/archinte.164.9.1010. (Pubitemid 38581522)
93. Ladwig KH, Marten-Mittag B, Lowel H, Doring A, Koenig W. C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998. Eur Heart J. 2005;26(23):2537-42. doi:10.1093/eurheartj/ehi456. (Pubitemid 41677304)
94. Hemingway H, Shipley M, Mullen MJ, Kumari M, Brunner E, Taylor M, et al. Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study). Am J Cardiol. 2003;92(8):984-7. (Pubitemid 37214817)
95. Thomas AJ, Ferrier IN, Kalaria RN, Woodward SA, Ballard C, Oakley A, et al. Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. Am J Psychiatry. 2000;157(10):1682-4.
96. Thomas AJ, Ferrier IN, Kalaria RN, Davis S, O'Brien JT. Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly. Br J Psychiatry. 2002;181:129-34. (Pubitemid 34864494)
97. Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O'Brien JT. Increase in interleukin-1beta in late-life depression. Am J Psychiatry. 2005;162(1):175-7. doi:10.1176/appi.ajp.162.1.175. (Pubitemid 40095688)
98. Thomas AJ, Morris C, Davis S, Jackson E, Harrison R, O'Brien JT. Soluble cell adhesion molecules in late-life depression. Int Psychogeriatr. 2007;19(5):914-20. doi:10.1017/S1041610206004728. (Pubitemid 47295891)